Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

412

HTML

4583

Figures (1-5)

278

Tables (1-7)

212

Sum=5485

Nov 14, 2010 (publication date) through Sep 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Nov 14, 2010; 16(42): 5297-5305
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5297

Table 1 Clinical features of the studied groups n (%)

Variables	Treated group (n = 90)	Control group (n = 50)
Age (yr, mean ± SD)	50.27 ± 6.05	50.9 ± 7.23
Sex
Male	78 (86.7)	39 (78)
Female	12 (13.3)	11 (22)
Residence
Urban	30 (33.33)	20 (40)
Rural	60 (66.66)	30 (60)
Jaundice	36 (40)	21 (42)
Encephalopathy	21 (23.33)	15 (30)
Weight loss	57 (63.33)	29 (58)
Ascites and lower limb edema	78 (86.66)	41 (82)
Peripheral erythema	75 (83.33)	39 (78)
Bleeding tendency	48 (53.33)	26 (52)
Hematemesis	24 (26.66)	12 (24)
Quantitative HCV RNA PCR (IU/mL)	1 128 230-1 810 530	1 235 650-1 754 150

HCV: Hepatitis C virus; PCR: Polymerase chain reaction.

Citation: Salama H, Zekri ARN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Alim SAA, Sherif GM. Autologous CD34⁺ and CD133⁺ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16(42): 5297-5305
URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5297.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5297